The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGuild Esports . Share News (GILD)

Share Price Information for Guild Esports . (GILD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.325
Bid: 0.30
Ask: 0.35
Change: 0.00 (0.00%)
Spread: 0.05 (16.667%)
Open: 0.317
High: 0.325
Low: 0.317
Prev. Close: 0.325
GILD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Guild Esports works to formalise strong pipeline of deals

Wed, 13th Jul 2022 17:53

Guild Esports PLC - London-based e-sports company - Notes recent share price movement and speculation over potential new sponsorship deals. Clarifies it has a "strong" pipeline of prospective deals at various stages of negotiation, and will announce when any contracts or agreements are formalised with new sponsors.

Current stock price: 1,75 pence, up 13% on Wednesday

12-month change: down 76%

By Elizabeth Winter; elizabethwinter@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
8 Dec 2020 18:08

IN BRIEF: Guild Esports Launches Branded Digital Product Range

IN BRIEF: Guild Esports Launches Branded Digital Product Range

Read more
19 Nov 2020 17:35

Guild Esports Adds Fortnite Player Flikk To Its Esports Player Roster

Guild Esports Adds Fortnite Player Flikk To Its Esports Player Roster

Read more
21 Oct 2020 20:26

IN BRIEF: Guild Esports Signs Team To Compete In Valorant Game

IN BRIEF: Guild Esports Signs Team To Compete In Valorant Game

Read more
19 Oct 2020 11:54

Guild Esports Inks GBP3.6 Million Sponsorship Deal With Fintech Firm

Guild Esports Inks GBP3.6 Million Sponsorship Deal With Fintech Firm

Read more
21 Mar 2018 07:00

FOCUS-GlaxoSmithKline prescribes commercial reboot for pharma division

* GSK reallocating budget to key new drugs, top 10 markets * Pharma head says commercial revamp matches R&D changes * Cancer a big pipeline focus, promise lies from Ben March 21

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.